Author

Mariabeatrice Rita Daniela Principi

REDUCED HUMORAL RESPONSE TO TWO DOSES OF COVID-19 VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA FROM ESCAPE-IBD, AN IG-IBD STUDY
REDUCED HUMORAL RESPONSE TO TWO DOSES OF COVID-19 VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA FROM ESCAPE-IBD, AN IG-IBD STUDY

Mariabeatrice Rita Daniela Principi  et al.

UPADACITINIB IN CONCURRENT SEVERE ATOPIC DERMATITIS, ALOPECIA AREATA AND CROHN’S DISEASE: A CASE REPORT
UPADACITINIB IN CONCURRENT SEVERE ATOPIC DERMATITIS, ALOPECIA AREATA AND CROHN’S DISEASE: A CASE REPORT

Mariabeatrice Rita Daniela Principi  et al.

DISSEMINATED NOCARDIOSIS INFECTION IN A PATIENT AFFECTED BY ULCERATIVE COLITIS
DISSEMINATED NOCARDIOSIS INFECTION IN A PATIENT AFFECTED BY ULCERATIVE COLITIS

Mariabeatrice Rita Daniela Principi  et al.

SMALL INTESTINAL CONTRAST ULTRASONOGRAPHY (SICUS) IN CROHN’S DISEASE: SYSTEMATIC REVIEW AND META-ANALYSIS
SMALL INTESTINAL CONTRAST ULTRASONOGRAPHY (SICUS) IN CROHN’S DISEASE: SYSTEMATIC REVIEW AND META-ANALYSIS

Mariabeatrice Rita Daniela Principi  et al.

TRANSITION FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB VERSUS VEDOLIZUMAB TREATMENT: A PROSPECTIVE MULTICENTER STUDY
TRANSITION FROM INTRAVENOUS TO SUBCUTANEOUS INFLIXIMAB VERSUS VEDOLIZUMAB TREATMENT: A PROSPECTIVE MULTICENTER STUDY

Mariabeatrice Rita Daniela Principi  et al.

REAL-LIFE EVALUATION OF GOLIMUMAB EFFECTIVENESS AND QUALITY OF LIFE IN PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS: THE PROSPECTIVE GO-CARE STUDY
REAL-LIFE EVALUATION OF GOLIMUMAB EFFECTIVENESS AND QUALITY OF LIFE IN PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS: THE PROSPECTIVE GO-CARE STUDY

Mariabeatrice Rita Daniela Principi  et al.

SAFETY OF COVID-19 VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA OF A NATIONAL STUDY (ESCAPE-IBD)
SAFETY OF COVID-19 VACCINE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: DATA OF A NATIONAL STUDY (ESCAPE-IBD)

Mariabeatrice Rita Daniela Principi  et al.

Item 1 - 7 / 7
1